Virpax Pharmaceuticals, Inc. (VRPX)
OTCMKTS
· Delayed Price · Currency is USD
0.2500
+0.0400 (19.05%)
Apr 17, 2025, 2:30 PM EDT
Virpax Pharmaceuticals Market Cap
Virpax Pharmaceuticals has a market cap or net worth of $272.00 thousand as of April 17, 2025. Its market cap has decreased by -94.42% in one year.
Market Cap
272.00K
Enterprise Value
-1.24M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.25
Market Cap Chart
Since February 17, 2021, Virpax Pharmaceuticals's market cap has decreased from 32.29M to 272.00K, a decrease of -99.16%. That is a compound annual growth rate of -68.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 272.00K | -85.35% |
| Dec 31, 2024 | 1.86M | -50.48% |
| Dec 29, 2023 | 3.75M | -48.56% |
| Dec 30, 2022 | 7.29M | -81.86% |
| Dec 31, 2021 | 40.18M | 24.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SS Innovations International | 1.84B |
| Endo Inc. | 1.62B |
| Nika Pharmaceuticals | 1.02B |
| Veradigm | 712.23M |
| Elite Pharmaceuticals | 448.67M |
| Northwest Biotherapeutics | 349.08M |
| Glass House Brands | 344.83M |
| CytoDyn | 258.69M |